<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250509065659N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-29</date_registration>
      <primary_sponsor>THE UNIVERSITY OF FAISALABAD</primary_sponsor>
      <public_title>IASTM vs DTFM on mechanical neck pain</public_title>
      <acronym>IASTM,DTFM,NPRS,NDI</acronym>
      <scientific_title>Comparative Effects of Instrumental Assisted Soft Tissue Mobilization and Deep Transverse Friction Massage in Patients with Mechanical Neck Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-05-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/83651</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Education/Guidance, Other design features: sampling technique, Randomization description: Randomization through sealed envelope. On probability convenient sampling will use for the study , group allocation will be done by chit and draw method, Blinding description: It is a single blind study, participants will be blinded as they will not know the treatment which they will receive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Mechanical neck painand cpmparative effects of instrumental assisted soft tissue mobilizaton and deep transverse friction massage.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Instrument- assisted soft tissue mobilization Patients are in this group will give a hot pack, before applying, the advantage of the Garston technique over other soft tissue mobilization techniques is that deeper restrictions can be accessible since the metallic exterior of the instruments, such as the deeper fingertip padding, has no impact on tissues. Due to its effectiveness and lack of invasiveness, the Garston procedure is expanding quickly. tips and margins of the apparatus. Lubricate the region that has been treated. For 40–120 seconds, try Garston at a 30–60 direction. This will improve blood supply to the tissues on both sides. If more redness develops after therapies, apply a pack of ice to reduce hyperemia. Intervention 2: Intervention group: Deep Transverse Friction MassageThis group of patients will get a deeply transverse the friction massage. To begin a heated pack will be utilized, and the treatment area must be cleaned with cotton and dried out before receiving treatment. Later power will be applied to the implementation. area to lessen friction, and the skin will be damp and talcum powder will be used. To avoid bruising it was crucial that the therapist's fingertips and the patient’s skin moved together as one throughout friction. Direct massage over the lesion and pain site is required. Instead of sliding over the skin, the fingers engage together it. This technique will cause numbness in the affected area after a few minutes. For four weeks, on three days a week 15-minute sessions were used for therapy.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is for concealing participants identity</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Noreen</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>WEST CANAL ROAD FAISALABAD ,FAISAL TOWN</address>
        <city>FAISALABAD</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 41 8750970</telephone>
        <email>clinical.trainer@tuf.edu.pk</email>
        <affiliation>THE UNIVERSITY OF FAISALABAD</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Noreen</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>WEST CANAL ROAD FAISALABAD ,FAISAL TOWN</address>
        <city>FAISALABAD</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 309 8827322</telephone>
        <email>clinical.trainer@tuf.edu.pk</email>
        <affiliation>THE UNIVERSITY OF FAISALABAD</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age group (18-40) year
Gender both (male and female)
Patient having neck pain score 5or more then 5
Patient having NDI score 14 or more
Patients with inclusive criteria asked to sign the written consent to take part in the research</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participants diagnose to any musculoskeltal or auto immune disorder
Any participant with congenital anomalies like cervical rib etc
Having past family history of radiculopathy of the cervical region and cervical trauma
Having any neurological or psychological complications and vascular disorder or infectious disease
Participant with bilateral trapezius spasm
Any participant with history of recent surgery to neck or upper trunk
Suffering from diabetes mellitus</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Instrument- assisted soft tissue mobilization Patients are in this group will give a hot pack, before applying, the advantage of the Garston technique over other soft tissue mobilization techniques is that deeper restrictions can be accessible since the metallic exterior of the instruments, such as the deeper fingertip padding, has no impact on tissues. Due to its effectiveness and lack of invasiveness, the Garston procedure is expanding quickly. tips and margins of the apparatus. Lubricate the region that has been treated. For 40–120 seconds, try Garston at a 30–60 direction. This will improve blood supply to the tissues on both sides. If more redness develops after therapies, apply a pack of ice to reduce hyperemia.</i_keyword>
      <i_keyword>Intervention group: Deep Transverse Friction MassageThis group of patients will get a deeply transverse the friction massage. To begin a heated pack will be utilized, and the treatment area must be cleaned with cotton and dried out before receiving treatment. Later power will be applied to the implementation. area to lessen friction, and the skin will be damp and talcum powder will be used. To avoid bruising it was crucial that the therapist's fingertips and the patient’s skin moved together as one throughout friction. Direct massage over the lesion and pain site is required. Instead of sliding over the skin, the fingers engage together it. This technique will cause numbness in the affected area after a few minutes. For four weeks, on three days a week 15-minute sessions were used for therapy.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>NUMERICAL PAIN RATING SCALE. Timepoint: 3 DAYS IN WEEK FOR 4 WEEKS. Method of measurement: 1-10 POINTS ON PAPER.</prim_outcome>
      <prim_outcome>RANGE OF MOTION OF NECK. Timepoint: 3 DAYS IN WEEK FOR 4 WEEKS. Method of measurement: GONIOMETER.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>NECK DISABILITY INDEX. Timepoint: 3 TIMES IN A WEEK. Method of measurement: QUESTIONNARE.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>THE UNIVERSITY OF FAISALABAD</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-20</approval_date>
        <contact_name>ETHICS COMMITTEE OF THE UNIVERSITY OF FAISALABAD</contact_name>
        <contact_address>No.West Canal Road .,Faisal Town Faisalabad Faisalabad Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
